Foghorn Therapeutics at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Foghorn Therapeutics takes part in 2 sessions at TPD Summit 2026 in Boston. Its sessions cover the direction of the induced proximity field and how proximity-based design can reach targets that are hard to drug.

OrganizationTPD Summit 2026 Attendance
foghorntx.com
Biotech
Clinical-stage biotech targeting the chromatin regulatory system with small molecules and protein degraders for cancer.
Panel
Tue Oct 27
9:00am
Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
Plenary · with Nurix Therapeutics, Stablix, C4 Therapeutics +1 more
Investment, partnering & strategy
Talk
Thu Oct 29
10:30am
Proximity by Design: Harnessing Induced Proximity for Challenging Targets
Future of Induced Proximity Track
Degrader discovery & design

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Foghorn Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction